健康元：健康元药业集团股份有限公司2023年第一季度报告（英文版）.PDF

1、Joincare Pharmaceutical Group Industry Co.,Ltd.2023 First Quarterly Report 1/12 Stock Code:600380 Stock Short Name:健康元 Joincare Pharmaceutical Group Industry Co.,Ltd.2023 First Quarterly Report The Board of Directors and all Directors of the Company hereby warrant that there are no false representat

2、ions,misleading statements or material omissions contained in this announcement and accept legal responsibility for the truthfulness,accuracy and completeness of the contents hereof.IMPORTANT NOTICE:The Board of Directors,the Board of Supervisors and Directors,Supervisors and senior management of th

3、e Company hereby warrant the truthfulness,accuracy and completeness of the contents of this quarterly report,and that there are no false representations,misleading statements or material omissions contained herein,and severally and jointly accept legal responsibility.The person-in-charge of the Comp

4、any,the person-in-charge of accounting work and the person-in-charge of the accounting department(the head of the accounting department)hereby warrant the truthfulness,accuracy and completeness of the financial information contained in this quarterly report.Whether the first quarterly financial stat

5、ements have been audited.Yes No I.MAJOR FINANCIAL DATA(I)Major Accounting Data and Financial Indicators Unit:Yuan Currency:RMB Item The Reporting Period (From January to March)YoY change(%)Revenues 4,559,049,786.82-2.11 Net profit attributable to shareholders of the listed company 462,746,183.03 0.4

6、8 Net profit attributable to shareholders of the listed company after deduction of extraordinary gains and losses 446,772,473.94-2.28 Net cash flow from operating activities 248,084,750.71-71.55 Basic earnings per share(RMB/share)0.2404-0.31 Diluted earnings per share(RMB/share)0.2398-0.48 Weighted